Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Highmark Health operates one of the largest integrated health care delivery and financing systems in the U.S., serving approximately 40 million Americans with insurance products and direct healthcare services. It reported $29.4 billion in consolidated revenues for 2024 and employs over 35,000 people. Its core businesses include health insurance plans under the Blue Cross Blue Shield brand in several states; hospital operations through Allegheny Health Network; dental solutions via United Concordia Dental; reinsurance through HM Insurance Group; IT solutions via enGen/HM Health Solutions; and population health management through Helion.
The company does not develop drugs or biologics but focuses on delivering care across hospitals/clinics and managing population health.
No clinical pipeline exists as it does not conduct drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Highmark Health.